John M. Maraganore
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John M. Maraganore
John M. Maraganore was last confirmed as Board Member at Prokidney Corp. (PROK) in a filing dated May 26, 2023. John M. Maraganore was last confirmed as Board Member at Agios Pharmaceuticals, Inc. (AGIO) in a filing dated April 26, 2023. Prokidney Corp. reported in an 8-K filed July 12, 2022 that John M. Maraganore was appointed Class II director.
“SCS shareholders approved by ordinary resolution the election of William F. Doyle, Alan M. Lotvin, M.D. and Brian J.G. Pereira, M.D. to serve as Class I directors, John M. Maraganore, Ph.D. and José Ignacio Jiménez Santos to serve as Class II directors and Tim Bertram, Ph.D., Pablo Legorreta and Uma Sinha, Ph.D. to serve as Class III directors, with Mr. Legorreta to serve as the Chairperson of the ProKidney Corp. board of directors, who, upon the Closing, will be the directors of ProKidney Corp.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-05-26
Last confirmed by a filing; no departure on record
-
Start not stated–2023-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.